REQUEST A DEMO
Total
USD $0.00
Search more companies

Adura Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ADURA PHARMA Egeszsegugyi es Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Adura Pharma Kft. is a company in Hungary, with a head office in Miskolc. It operates in the Pharmacies and Drug Stores industry. It was incorporated on December 05, 2011. There are currently 4 (2024) people employed by Adura Pharma Kft.. There was a net sales revenue increase of 13.67% reported in Adura Pharma Kft.’s latest financial highlights for 2023. There was a total growth of 5.13% in Adura Pharma Kft.’s total assets over the same period. In 2023, Adura Pharma Kft.’s net profit margin increased by 0.35%.

Headquarters
Klapka Gyorgy utca 9-11.
Miskolc; Borsod-Abauj-Zemplen; Postal Code: 3524

Contact Details: Purchase the Adura Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Adura Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Adura Pharma Kft. report to view the information.
Registered Capital:
Purchase the Adura Pharma Kft. report to view the information.
Incorporation Date:
December 05, 2011
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Adura Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
13.67%
Total operating revenue
14.14%
Operating profit (EBIT)
70.11%
EBITDA
58.41%
Net Profit (Loss) for the Period
37.24%
Total assets
5.13%
Total equity
-9.85%
Operating Profit Margin (ROS)
0.91%
Net Profit Margin
0.35%
Return on Equity (ROE)
2.29%
Quick Ratio
-0.34%
Cash Ratio
0.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?